Methyl-2-fluoro-3,3,3-trimethoxypropionate, 97.0%, 1g

1-tert-Butyl 3-ethyl 4-hydroxypyrrolidine-1,3-dicarboxylate, 98%, 1g

6-methyl-1,2,3,4-tetrahydro-1,8-naphthyridine, 95.0%, 500mg

(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(((tert-butoxycarbonyl)amino)methyl)phenyl)propanoic acid, 95+%, 500mg

5-Cyclopropyl-2-fluoro-4-methylpyridine, 97%, 5g

tert-Butoxytrimethylsilane, 95%, 5g

3-Bromobenzenesulfonyl chloride, 97.0%, 5g

Plan de larga distancia de trabajo fase 4x/0,13 Objetivo IOS, distancia de trabajo 10,75 mm

ethyl 4-hydrazinobenzoate hydrochloride, 95.0%, 5g

3,5-Diphenyl-1H-pyrazole, 95.0%, 5g

n-Ethyl-4-nitroaniline, 97%, 5g

1-Vinylimidazole Bis(trifluoromethanesulfonyl)imide>98.0%(HPLC)(T)5g

Methyl 3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-5-carboxylate, 95+%, 250mg